Pay in 4 interest-free payments of $5.13 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
This tells you if it's covered and at what tier
Prevalence of persistent symptoms after treatment for lyme borreliosis: A prospective observational cohort study
This process helps protect the skin from harmful UV radiation
Prophylaxis of Influenza The safety and efficacy of TAMIFLU for the prophylaxis of influenza in pediatric patients 1 year to 17 years old has been established [see Dosage and Administration (2.3), Clinical Pharmacology (12.3), and Clinical Studies (14.2)] and is based on: The safety and efficacy of TAMIFLU for prophylaxis of influenza have not been established for pediatric patients less than 1 year of age
Drosophila stocks and generation of UAS-HA-V5-LaccID flies Flies were maintained on standard cornmeal medium on a 12-h lightdark cycle at 25 C
Read the announcement: To view or add a comment, sign in BREAKING NEWS: The Food and Drug Administration (FDA) has approved Gazyva (obinutuzumab) for the treatment of adults living with lupus nephritis, supported by positive Phase II and III trial results
US$ 22.98
US$ 25.02
US$ 25.34
US$ 22.13
US$ 25.04
US$ 28.49
US$ 23.59
